120996 Results for: "Hafnium(IV)+sulphate&pageNo=14"

Supplier: Abcam

Rabbit monoclonal [EPR21714-145] to IL-6R - BSA and Azide free (Capture).

Supplier: Abcam

Rabbit monoclonal [EPR26538-16] to CD8 beta - BSA and Azide free.

Supplier: Abcam

Rabbit monoclonal [EPR22929-13] to Annexin-4/ANXA4 - BSA and Azide free (Capture).

Supplier: Abcam

Rabbit monoclonal [EPR19954-208] to IL-18 - BSA and Azide free (Detector).

Supplier: Abcam

Rabbit monoclonal [EPR19578-134] to Cyclin D1 - BSA and Azide free (Capture).

Supplier: Abcam

Mouse monoclonal [18/Smad2/3] to Smad2 + Smad3 - BSA and Azide free.

Supplier: Apollo Scientific

3-(3,5-Dibromo-1H-1,2,4-triazol-1-yl)butan-2-one, tech

Supplier: Apollo Scientific

4-{[2-Oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzoic acid, tech

Supplier: Abcam

Mouse monoclonal [CDH16/1071] to Cadherin 16 - BSA and Azide free.

Supplier: Apollo Scientific

(2-Mercapto-4-oxo-4,5-dihydro-1,3-thiazol-5-yl)acetic acid

Supplier: Abcam

Mouse monoclonal [BA-17] to Cytokeratin 19.

Supplier: Apollo Scientific

(1S,2R)-cis-4-Cyclohexene-1,2-dicarboxylic acid 1-monomethyl ester

Supplier: Apollo Scientific

5-(4-Bromophenyl)-4-methyl-2,4-dihydro-3H-1,2,4-triazole-3-thione 95%

Supplier: Apollo Scientific

6-Ethoxyspiro[benzo[e][1,3]oxazine-2,4'-piperidin]-4(3H)-one hydrochloride

Supplier: Apollo Scientific

Ethyl 3-methyl-5,6-dihydroimidazo[2,1-b][1,3]thiazole-2-carboxylate hydrochloride

Supplier: Apollo Scientific

1-(2,3-Difluorophenyl)-N-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]methanamine

Supplier: Thermo Fisher Scientific

Palladium ≥99.95% (metals basis), wire, annealed, Ø 0.4 mm (0.0159 in)

Supplier: Abcam

Mouse monoclonal [M13/12] to Complement factor B.

Supplier: Thermo Fisher Scientific

Rhodium(III) chloride solution 10 - 30% w/w (cont. Rh) 99.5% (w/w)

Supplier: Thermo Fisher Scientific

(2S,5S)-1-[2-(1,3-Dioxolan-2-yl)phenyl]-2,5-dimethylphospholane 97%

Supplier: Thermo Fisher Scientific

Reagent 50% wet with water for safety

Supplier: Apollo Scientific

Pyrrolo[2,1-f][1,2,4]triazine-2,4(1H,3H)-dione 95%

Supplier: Biotium

Recognizes a glycoprotein of ~200 kDa, identified as carbonic anhydrase IX (CAIX/gp200). Its epitope resides in the carbohydrate domain of gp200. It shows no significant cross-reactivity with other carbohydrate determinants, such as the Lewis blood group antigens, epithelial membrane antigen, HMFG, and AB blood group antigens. In normal kidney, gp200 is localized along the brush border of the pars convoluta and pars recta segments of the proximal tubule, as well as focally along the luminal surface of Bowman's capsule adjoining the outgoing proximal tubule. Reportedly, gp200 is expressed by 93% of primary and 84% of metastatic renal cell carcinomas. This MAb may be useful in the investigations of carcinomas of proximal nephrogenic differentiation especially those showing tubular differentiation.

Supplier: Biotium

This antibody recognizes an oncofetal glycoprotein with a single chain of 70 kDa, which is identified as alpha fetoprotein (AFP). This MAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. The yolk sac and the liver produce AFP during fetal life. AFP expression in adults is often associated with hepatoma or teratoma. However, hereditary persistence of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the AFP and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. AFP is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of AFP in amniotic fluid is used to measure renal loss of protein to screen for spinal bifida and anencephaly.

Supplier: Biotium

This MAb recognizes a single chain, transmembrane, heavily glycosylated protein of 90-120 kDa, which is identified as CD34. On the basis of differential sensitivity to degradation by specific enzymes, epitopes of monoclonal antibodies to CD34 are classified intothree main categories, class I, class II and class III. It is a class II antibody whose epitope is resistant to neuraminidase but sensitive to glycoprotease and chymopapain.CD34 expression is a hallmark for identifying pluripotent hematopoietic stem or progenitor cells. Its expression is gradually lost as lineage committed progenitors differentiate. CD34 is a marker of choice for staining blasts in acute myeloid leukemia. In addition, CD34 is expressed by soft tissue tumors, such as solitary fibrous tumor and gastrointestinal stromal tumor. Its expression is also found in vascular endothelium. Additionally, it appears that proliferating endothelial cells express this molecule more than the non-proliferating endothelial cells. Anti-CD34 labels > 85% of angiosarcoma and Kaposi's sarcoma, but with a lower specificity.

Supplier: Biotium

Recognizes a single chain glycoprotein of 70 kDa, identified as CD55 (also known as decay accelerating factor, DAF). CD55/DAF is widely expressed on cells throughout the body including leukocytes, erythrocytes, epithelium, endothelium, and fibroblasts. It is a Glycosyl phosphatidylinositol anchored (GPI-anchored) member of the membrane bound complement regulatory proteins that inhibit autologous complement cascade activation. It prevents the amplification steps of the complement cascade by interfering with the assembly of the C3-convertases, C4b2a and C3bBb, and the C5-convertase, C4b2a3b and C3bBb3b. CD55 also serves as receptor for CD97 and for echovirus and Coxsackie B virus. The MAb 143-30 can be used as marker for paroxysmal nocturnal hemoglobinuria (PNH).

Supplier: Biotium

This MAb recognizes a single chain, transmembrane, heavily glycosylated protein of 90-120 kDa, which is identified as CD34. On the basis of differential sensitivity to degradation by specific enzymes, epitopes of monoclonal antibodies to CD34 are classified intothree main categories, class I, class II and class III. It is a class II antibody whose epitope is resistant to neuraminidase but sensitive to glycoprotease and chymopapain.CD34 expression is a hallmark for identifying pluripotent hematopoietic stem or progenitor cells. Its expression is gradually lost as lineage committed progenitors differentiate. CD34 is a marker of choice for staining blasts in acute myeloid leukemia. In addition, CD34 is expressed by soft tissue tumors, such as solitary fibrous tumor and gastrointestinal stromal tumor. Its expression is also found in vascular endothelium. Additionally, it appears that proliferating endothelial cells express this molecule more than the non-proliferating endothelial cells. Anti-CD34 labels > 85% of angiosarcoma and Kaposi's sarcoma, but with a lower specificity.

Supplier: Biotium

This MAb recognizes a single chain, transmembrane, heavily glycosylated protein of 90-120 kDa, which is identified as CD34. On the basis of differential sensitivity to degradation by specific enzymes, epitopes of monoclonal antibodies to CD34 are classified intothree main categories, class I, class II and class III. It is a class II antibody whose epitope is resistant to neuraminidase but sensitive to glycoprotease and chymopapain.CD34 expression is a hallmark for identifying pluripotent hematopoietic stem or progenitor cells. Its expression is gradually lost as lineage committed progenitors differentiate. CD34 is a marker of choice for staining blasts in acute myeloid leukemia. In addition, CD34 is expressed by soft tissue tumors, such as solitary fibrous tumor and gastrointestinal stromal tumor. Its expression is also found in vascular endothelium. Additionally, it appears that proliferating endothelial cells express this molecule more than the non-proliferating endothelial cells. Anti-CD34 labels > 85% of angiosarcoma and Kaposi's sarcoma, but with a lower specificity.

Supplier: Biotium

This MAb recognizes a single chain, transmembrane, heavily glycosylated protein of 90-120 kDa, which is identified as CD34. On the basis of differential sensitivity to degradation by specific enzymes, epitopes of monoclonal antibodies to CD34 are classified intothree main categories, class I, class II and class III. It is a class II antibody whose epitope is resistant to neuraminidase but sensitive to glycoprotease and chymopapain.CD34 expression is a hallmark for identifying pluripotent hematopoietic stem or progenitor cells. Its expression is gradually lost as lineage committed progenitors differentiate. CD34 is a marker of choice for staining blasts in acute myeloid leukemia. In addition, CD34 is expressed by soft tissue tumors, such as solitary fibrous tumor and gastrointestinal stromal tumor. Its expression is also found in vascular endothelium. Additionally, it appears that proliferating endothelial cells express this molecule more than the non-proliferating endothelial cells. Anti-CD34 labels > 85% of angiosarcoma and Kaposi's sarcoma, but with a lower specificity.

Supplier: Apollo Scientific

1,7-Diazaspiro[3.5]nonane-7-carboxylic acid tert-butyl ester